However, inoculation of ex vivo infected CD34+ cells might represent a bias since the presence of HTLV-1 infected cells among CD34+ cells in ATLL patients is still a matter of debate [56]. This evidence concerns the gene CD34 and adult T-cell leukemia/lymphoma.